HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BAY 2315497

A human anti-PSMA antibody covalently linked to a 3,2-HOPO (hydroxypyridinone) chelator moiety radiolabeled with the alpha-particle emitter thorium-227.

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        BAY 2315497: 1
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        BAY 2315497: 1
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        BAY 2315497: 1

Experts

1.	Bader, Benjamin: 1 article (01/2021)
2.	Bartels, Florian: 1 article (01/2021)
3.	Berger, Markus: 1 article (01/2021)
4.	Briem, Hans: 1 article (01/2021)
5.	Buchgraber, Philipp: 1 article (01/2021)
6.	Bömer, Ulf: 1 article (01/2021)
7.	Eberspächer, Uwe: 1 article (01/2021)
8.	Eis, Knut: 1 article (01/2021)
9.	Hammer, Stefanie: 1 article (01/2021)
10.	Lienau, Philip: 1 article (01/2021)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2021 - "Combination of PSMA-targeted thorium-227 conjugate BAY 2315497 treatment of human prostate tumor-bearing mice with BAY-8400 oral treatment increased antitumor efficacy, as compared to PSMA-targeted thorium-227 conjugate monotherapy."

Related Drugs and Biologics

1.	Thorium-227